APLP2 Antikörper
-
- Target Alle APLP2 Antikörper anzeigen
- APLP2 (Amyloid beta (A4) Precursor-Like Protein 2 (APLP2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APLP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human APLP2 (NP_001135750.1).
- Isotyp
- IgG
- Top Product
- Discover our top product APLP2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- APLP2 (Amyloid beta (A4) Precursor-Like Protein 2 (APLP2))
- Andere Bezeichnung
- APLP2 (APLP2 Produkte)
- Synonyme
- HAI antikoerper, MT-SP1 antikoerper, MTSP1 antikoerper, PRSS14 antikoerper, SNC19 antikoerper, TADG15 antikoerper, TMPRSS14 antikoerper, APLP-2 antikoerper, APPH antikoerper, APPL2 antikoerper, CDEBP antikoerper, AI790698 antikoerper, Apph antikoerper, WALPLP2 antikoerper, aplp2 B antikoerper, APLP2 antikoerper, si:dkey-11k4.3 antikoerper, aplp2 A antikoerper, MGC86389 antikoerper, suppression of tumorigenicity 14 antikoerper, amyloid beta precursor like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 antikoerper, amyloid beta (A4) precursor-like protein 2 S homeolog antikoerper, amyloid beta (A4) precursor-like protein 2 L homeolog antikoerper, ST14 antikoerper, APLP2 antikoerper, Aplp2 antikoerper, aplp2.S antikoerper, aplp2 antikoerper, aplp2.L antikoerper
- Hintergrund
- This gene encodes amyloid precursor- like protein 2 (APLP2), which is a member of the APP (amyloid precursor protein) family including APP, APLP1 and APLP2. This protein is ubiquitously expressed. It contains heparin-, copper- and zinc- binding domains at the N-terminus, BPTI/Kunitz inhibitor and E2 domains in the middle region, and transmembrane and intracellular domains at the C-terminus. This protein interacts with major histocompatibility complex (MHC) class I molecules. The synergy of this protein and the APP is required to mediate neuromuscular transmission, spatial learning and synaptic plasticity. This protein has been implicated in the pathogenesis of Alzheimer's disease. Multiple alternatively spliced transcript variants encoding different isoforms have been identified.
- Molekulargewicht
-
Observed_MW: 87 kDa
Calculated_MW: 59 kDa/79 kDa/80 kDa/85 kDa/86 kDa/87 kDa
- Gen-ID
- 334
- UniProt
- Q06481
- Pathways
- EGFR Signaling Pathway, Transition Metal Ion Homeostasis, Feeding Behaviour
-